Novaturas AB

As of June 30, 2025, Novaturas AB carries a market capitalization of 60.92M, placing it among publicly traded companies globally. Its enterprise value stands at 97.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Novaturas AB's next confirmed earnings release is scheduled for February 26, 2027.

As of June 30, 2025, Novaturas AB has 7.75M shares outstanding.

These figures are as of June 30, 2025.

As of June 30, 2025, Novaturas AB maintains a current ratio of 0.57, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2025.

Over the twelve months ended June 30, 2025, Novaturas AB recorded an income tax benefit of -12,730.18 rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 22, 2026, Novaturas AB's stock has declined approximately 16.55% over the past 52 weeks. The 50-day moving average sits at 4.88, while the 200-day moving average is 5.93.

As of June 30, 2025, Novaturas AB holds 21.43M in cash and equivalents against 57.81M in total debt, resulting in a net debt position of 49.93M. Total book value stands at 30.68M, with working capital of -49.31M providing operational flexibility.